Another Big ex-Janssen Player Sitting At The Geron Table Now......

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
kmall
Posts: 399
Joined: Thu Mar 21, 2019 3:57 pm

Another Big ex-Janssen Player Sitting At The Geron Table Now......

Post by kmall » Wed Nov 30, 2022 10:35 pm

Oliver Gessner - Sr. Director, Business Insights and Analytics, Hematology at Geron Corporation

Hired - Sept 2022

9/22/2022 - FOSTER CITY, Calif.- (BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN) reported that it has granted non-statutory stock options to purchase an aggregate of 901,950 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company. Oliver Gessner is one of these newly hired employees.

Oliver Gessner's former employers include: Janssen, Novartis, Bayer, Genmab, Bristol Meyers Squibb, Somaxon Pharmaceuticals, BASF/Knoll Pharma, Nycomed

"20 year experience in analytics and consulting in large- and small pharma companies with demonstrated learning agility; proven ability to integrate insights that drive business decisions; successful at managing and developing business relationships; multi-year people management experience with ability to empower accountable individuals"


Genmab: Director, Global Business Insights Oncology

Janssen: AD Global Analytics, Hematology; Associate Dir., Global Analytics Solid Tumors; AD, US New Business Development

Novartis: Associate Director Business Analysis; Associate Dir. Oncology Market Research

Bristol Meyers Squibb: Associate Director US Oncology Market Research, Yervoy

Bayer: Sr. Manager Mkt. Research; Sr. Analyst, Manager Market Research Dermatology US


*Oliver's hiring at Geron marks the 5th of the last 7 newly hired employees who were previously employed by either Janssen/JNJ.

A "strategic portfolio" decision sometimes requires more time for data to mature or possibly a contract reassessment? Of course no one knows for certain, except those involved at the time, but ex-JNJ employees finding their way onto the Geron employee roster now and in the positions they hold, is proving the "flimsy data" argument rather flimsy. -Kmall

kmall
Posts: 399
Joined: Thu Mar 21, 2019 3:57 pm

Re: Another Big ex-Janssen Player Sitting At The Geron Table Now......

Post by kmall » Wed Nov 30, 2022 10:51 pm

Known current Geron Employees as of 11/30/2022 and their initial hiring dates –
* Former Janssen employee
+ Part-time or Consultant

Management:
1 - CEO – Dr. John A. Scarlett, MD - 2011
2 - CFO – Olivia K. Bloom - 1994
3 - CAO – Melissa A. Kelly Behrs – 1998
4 - CBO – Edward Koval - 2021
5 - COO – Andrew J. Grethlein - 2012
6 - CCO* – Anil Kapur - 2019
7 - CMO* – Faye Feller, MD - 2019
8 - CLO – Stephen N. Rosenfield - 2011

Clinical – Operations, Science, Development:
Faye Feller*(7), MD – CMO – 2019
9 - Laurie Sherman* – VP Clinical Operations – 2019
10 - Souria Dougherty* - Ex Director Clinical Science - 2019
11 - Tymara Berry – Ex Director Clinical Development - 2020
12 - Dr. Vivian Rodolf - Medical Director - 2022
13 - Sheetal Shah – Sr Director – 2020
14 - Denise Redding – Director - 2021
15 - Jeff Ryel – Director Clinical Operations - 2020
16 - Brandie Jonas – Sr Director, Clinical Program Management – 2019
17 - F Matthew Bakthasekaran - Sr Manger, Clinical Program Management - 2022
18 - Judy Ho - Sr Manager - 2022
19 - Natasha M - Associate Director, Clinical Research - 2021
20 - Manoj Jivani - Director Clinical Operations - 2022
21 - Kate Turner - Associate Director Clinical Operations - 2022
22 - Jennifer Riggs* - Associate Director Clinical Science - 2022
23 – Carolina Jacobs – Sr Project Manager - 2012
24 - Daria Zielinska – Sr Scientist – 2001
25 - Ron Pruzan – Principal Scientist – 2010
26 – Yelena Polonskaya – Sr Research Associate - 2001
27 - Barbara Mandelkow (Germany) Lab Assistant - 2017
28 - Janet Ahern(+) - Clinical Research Consultant - 2022
29 - Dr. Aleksandra Rizo*(+) - Sr. Medical and Regulatory Advisor - 2019
(currently employed at Vividion and Geron)
30 - Mebratu Gebreyesus(+) - Sr Development Associate - 2010
(currently employed at Bayer, Celltheon and Geron)
31 - Kerry Mundt(+) – CT Assistant – 2010
(currently employed by Pharmacyclics/Abbvie and Geron)

Pharmacovigilance and Drug Safety/Information:
32 - Patti N. – Ex Director Drug Safety – 2020
33 - Annat Ikin - Director Medical Writing – 2021

Business Development:
Melissa A. Kelly Behrs (3) – Chief Alliance Officer – 2014
Edward Koval (4) – CBO - 2021
Anil Kapur* (6) - COO - 2019
34 - Jason Grossman - Ex Director, Commercial Operations - 2022
35 - Nishan Sengupta - VP, Market-Access, Pricing, Evidence Strategy - 2021
36 - Scott Hutson - VP Sales - 2022
37 - Denise Meyer – VP Medical Affairs – 2022
38 - Oliver Gessner* - Sr. Director, Business Insights and Analytics, Hematology - 2022
39 - Lorraine S - VP Marketing - 2022
40 - Christopher Cornell - Sr. Field Medical Liaison - 2022
41 - Helen Lee – Sr. Reporting Analyst - 2012
42 - Anthony Kuczynski – Analyst - 2019
43 - Aron Feingold - VP Investor Relations & Corporate Communication - 2022

Finance:
Olivia K. Bloom (2) – CFO – 1994
44 - Karen Boyce – VP -2008
45 - Andrew Good – Ex Director – 2006
46 - Gilian Fong – Director – 2021
47 – Iasko Cable – Sr. Clinical Trial Accountant – 2019
48 – Dave Clark – CPA, Corporate Controller - 2022
49 - Katherine Harmon, CPA, Assistant Controller - 2022

Data Management:
50 - Ben Thorp - Head of Clinical Data Management - 2022
51 - Sarfraz Haroon - Associate Director, Clinical Data Management - 2022
52 - Rana F.* – Director, Statistical Programming - 2020
53 - Sridevi Sridhar, CCDM – Associate Director – 2021
54 - Aswin Jayaraman - Director, IT Applications - 2022

Manufacturing:
55 - Patrick Murphy – VP Manufacturing – 2019
56 - Eric Mueller – Director – 2019
57 - Leslie C. – CMC Director - 2021
58 - Bharat Baral* – CMC Manager – 2021 & 2011
59 - William Garzon-Rodriguez* - Associate Director Drug Product Manufacturing – 2021
60 - Tim Tickner – Director, Supply Chain Management – 2022

Regulatory:
61 - Sharon McBain* - VP Global - 2019
62 - Shirin Mirshamsi* – Director EU – 2019
63 - Ilesh Sanathra* - Director Global – 2020
64 - Nick Lyon –Sr Director – 2020
65 – Ronan Balicanta* Sr Manager, Submissions - 2022
66 - Tarin Araujo - Sr Manager US - 2022
67 - Joyce Reader - Sr Regulatory Consultant (+) - 2022

Biostatistics:
68 - Ying Wan* – VP - 2019
69 - Libo Sun* – Director - 2019

Quality Assurance and Quality Control:
70 - Denise Grippo – VP Quality and Compliance – 2019
71 - Samantha Taylor – QA Manager, Document Control – 2007
72 - Joe Denton – Director – 2019
73 - Damanjit Singh – Sr Manager – 2018
74 - Willie Mobley – Materials/Document Specialist - 2007
75 - Leah Wood – Manager – 2021
76 - Murugappa Vedachalam (+) – QA/QC/CMC Consultant - 2019

Legal and Intellectual Property:
Stephen L. Rosenfield (8) – CLO – 2011
77 - Pamela Smith – Associate General Counsel - 1999
78 - Christopher Johnson – Director - 2019
79 - Laura Reederson – Director - 2020
80 - Leslie Mooi – VP IP – 2007
81 - Abby B. – Sr Patent Paralegal - 2014
82 - Cheryl Northern – Sr. Contracts Manager – 2007
83 – Brittney Hernandez – Contracts Manager – 2021

Facilities Operations and Information Technology:
84 - Michael Yamada – VP -2007
85 - Jyoti Shetty – Sr Director IT – 2021
86 - John Albert - Director Information Technology Infrastructure - 2022
87 - Tim W - Associate Director, IT Business Systems - 2022
88 - Miguel Hundelt – Systems Administrator – 2018
89 – Julian Cornejo - Systems Administrator - 2021
90 - Briana Martinez – Ex Assistant - 2006
91 - Julia Mensing – Ex Assistant – 2011
92 - Stacie W. – Ex Assistant - 2020
93 - Mia Pham – Office Manager - 2020

Human Resources:
94 - Shannon Odam – HR Executive -2019
95 - Stephanie Dellari – Director - 2004
96 - Susan Finan – Employee Benefits – 2021
97 - Marisa Cerniglia - Manager, People Operations – 2021
98 – Jennifer Allen - Associate Director, Talent Acquisition – 2022
99 – Fiona McAuliffe – Talent Acquisition Associate - 2022

**This latest "known" Geron employee roster reflects the most recent additions of:

36 - Scott Hutson - VP Sales
38 - Oliver Gessner - Sr. Director, Business Insights and Analytics
39 - Lorraine S - VP MMarketing
51 - Sarfraz Haroon - Associate Director, Clinical Data Management
54 - Aswin Jayaraman - Director, IT Applications
67 - Joyce Reader - Senior Regulatory Consultant (+)


Former Janssen and JNJ employees now at Geron:

Janssen -
1. Dr. Aleksandra Rizo - Sr. Medical and Regulatory Advisor - 2019
2. Dr. Faye Feller, MD – CMO – 2019
3. Laurie Sherman – VP Clinical Operations – 2019
4. Souria Dougherty - Ex Director Clinical Science - 2019
5. Jennifer Riggs - Associate Director Clinical Science - 2022
6. Anil Kapur - COO - 2019
7. Oliver Gessner - Sr. Director, Business Insights and Analytics, Hematology - 2022
8. Rana F. – Director, Statistical Programming - 2020
9. Bharat Baral – CMC Manager – 2021 & 2011
10. William Garzon-Rodriguez - Associate Director Drug Product Manufacturing – 2021
11. Sharon McBain - VP Global Regulatory - 2019
12. Shirin Mirshamsi – Director EU, Regulatory – 2019
13. Ilesh Sanathra - Director Global, Regulatory – 2020
14. Ronan Balicanta - Sr Manager, Regulatory Submissions - 2022
15. Ying Wan – VP, Biostatistics - 2019
16. Libo Sun – Director, Biostatistics - 2019


JNJ
1. Nishan Sengupta - VP, Market-Access, Pricing, Evidence Strategy - 2021
2. Scott Hutson - VP Sales - 2022
3. Lorraine S - VP Marketing - 2022
4. Tarin Araujo - Sr Manager US, Regulatory - 2022
5. Joyce Reader - Sr Regulatory Consultant UK, Regulatory - 2022

***As of now, this is the current list of "known" ex-Janssen and ex-JNJ employees now working at Geron. Most likely more to come. -Kmall
Last edited by kmall on Sun Dec 04, 2022 2:16 pm, edited 1 time in total.

Bridge to Sell
Posts: 48
Joined: Sat Mar 19, 2022 11:33 pm

Re: Another Big ex-Janssen Player Sitting At The Geron Table Now......

Post by Bridge to Sell » Sun Dec 04, 2022 3:03 am

Nick Lyon was recently promoted to Senior Director, Head of CMC Regulatory.

https://www.linkedin.com/in/nick-lyon-246813b/

kmall
Posts: 399
Joined: Thu Mar 21, 2019 3:57 pm

Re: Another Big ex-Janssen Player Sitting At The Geron Table Now......

Post by kmall » Sun Dec 04, 2022 11:54 am

Yes, that information was passed on here 2 months ago.

viewtopic.php?f=1&t=1391

Bridge to Sell
Posts: 48
Joined: Sat Mar 19, 2022 11:33 pm

Re: Another Big ex-Janssen Player Sitting At The Geron Table Now......

Post by Bridge to Sell » Sun Dec 04, 2022 1:58 pm

I mention it here in the interest of keeping THIS list current.

kmall
Posts: 399
Joined: Thu Mar 21, 2019 3:57 pm

Re: Another Big ex-Janssen Player Sitting At The Geron Table Now......

Post by kmall » Sun Dec 04, 2022 2:11 pm

As stated.....it WAS mentioned 2 months ago. "THIS" list, which I've compiled and maintained to the best of my ability is CURRENT. New hires, any relevant promotions and those employees who have departed are mentioned in subsequent updates. If interested in any updates, simply go back to postings on employees here to search additional information. Hope this helps to clarify? -Kmall

biopearl123
Posts: 1105
Joined: Fri Jul 20, 2018 5:13 pm

Re: Another Big ex-Janssen Player Sitting At The Geron Table Now......

Post by biopearl123 » Sun Dec 04, 2022 5:50 pm

Thank you both for your contributions. A little review and reiteration is healthy and this up to date list has really continued to be the best indication of Geron’s future plans and quite frankly has been one of the primary generators of optimism for the hundreds of readers of this board. To this end please see next post.

Post Reply